Literature DB >> 4588853

5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment.

R Sjöström.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4588853     DOI: 10.1007/bf00562430

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  21 in total

1.  Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

Authors:  H R Bourne; W E Bunney; R W Colburn; J M Davis; J N Davis; D M Shaw; A J Coppen
Journal:  Lancet       Date:  1968-10-12       Impact factor: 79.321

2.  Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect.

Authors:  I P Lapin; G F Oxenkrug
Journal:  Lancet       Date:  1969-01-18       Impact factor: 79.321

Review 3.  Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.

Authors:  A T Moir; G W Ashcroft; T B Crawford; D Eccleston; H C Guldberg
Journal:  Brain       Date:  1970       Impact factor: 13.501

4.  5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis.

Authors:  R Sjöström; B E Roos
Journal:  Eur J Clin Pharmacol       Date:  1972-06       Impact factor: 2.953

Review 5.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

6.  Mass spectral identification of probenecid metabolites in rat bile.

Authors:  A M Guarino; W D Conway; H M Fales
Journal:  Eur J Pharmacol       Date:  1969-11       Impact factor: 4.432

7.  5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid.

Authors:  H M van Praag; J Korf; J Puite
Journal:  Nature       Date:  1970-03-28       Impact factor: 49.962

8.  Identification and renal excretion of probenecid metabolites in man.

Authors:  J M Perel; R F Cunningham; H M Fales; P G Dayton
Journal:  Life Sci I       Date:  1970-12-01

9.  Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.

Authors:  H C Guldberg; G W Ashcroft; T B Crawford
Journal:  Life Sci       Date:  1966-09       Impact factor: 5.037

10.  The accumulation of ( 14 C)5-hydroxyindol-3-ylacetic acid by the rabbit choroid plexus in vitro.

Authors:  I A Pullar
Journal:  J Physiol       Date:  1971-07       Impact factor: 5.182

View more
  5 in total

1.  Relationship of age and mood to monoamine metabolites in cerebrospinal fluid in parkinsonism.

Authors:  A K Granerus; T Magnusson; B E Roos; A Svanborg
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

Review 2.  Physiological and pathological changes in tissue monoamine oxidase activity.

Authors:  M B Youdim; M Holzbauer
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

3.  Clinical observations with pizotifene (Sandomigran) in the treatment of nonmigrainous depressed women.

Authors:  C M Banki
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-03-07

Review 4.  Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide.

Authors:  M Mayersohn; T W Guentert
Journal:  Clin Pharmacokinet       Date:  1995-11       Impact factor: 6.447

5.  5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology.

Authors:  F K Goodwin; R M Post
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.